Brand Institute

James L. Dettore

Founder, Chairman and Chief Executive Officer

James Dettore, senior strategist and founder of Brand Institute in 1993, has been instrumental in advancing BI’s hallmark of innovation and excellence. In 2004, he extended this legacy by establishing Drug Safety Institute (DSI), which has since become a premier company known for providing unparalleled expertise and cutting-edge regulatory services, setting the industry standard.

Mr. Dettore is an alumnus of the Harvard University Graduate School of Business Administration and currently serves on the Executive Committee of the Harvard University New York Chapter Owner & President Management Program (OPM).

In recognition of BI and DSI’s unwavering support of the pharmacy profession and commitment to patient safety, Mr. Dettore was inducted into the Phi Lambda Sigma Pharmacy Leadership Society in 2020. With over three decades of experience in brand management, he has held key positions at renowned organizations, including PepsiCo, J. Walter Thompson, Hilton International Hotels, and Ralph Lauren.

With gratitude for our remarkable and loyal clientele, Brand Institute has achieved the distinction of being the global leader in pharmaceutical and healthcare-related name and brand identity development. We are honored to have partnered on a portfolio of over 4,600 marketed healthcare brand names and 1,600 USAN/INN (nonproprietary names). This includes over 75 percent of pharmaceutical brand and nonproprietary name approvals globally every year. In the field of oncology alone, we have developed over 850 brand and nonproprietary names, catering to a wide spectrum of clients, from start-up biotech firms to esteemed global pharmaceutical conglomerates. Our success is a direct result of the trust and collaboration of over 1,400 valued clients.

In addition to creating names for pharmaceutical products, Brand Institute has vast experience in developing company names (for new companies as well as rebranding existing ones), clinical trial names, medical device names, OTC product names, technology names, and program names. Our portfolio of services includes name development, trademark searches, market research, visual identity, and regulatory solutions.

Brand Institute’s regulatory services are provided through its wholly owned subsidiary, Drug Safety Institute, which is composed of former regulatory naming officials from global government health agencies, including the U.S. Food and Drug Administration, European Medicines Agency, Health Canada, American Medical Association, and the World Health Organization. These experts offer industry-leading guidance and services related to drug name safety (i.e., preventing medication errors), packaging, and labeling.

James L. Dettore

Founder, Chairman and Chief Executive Officer

Brand Institute

Member Organizations

Become a partner to help join the fight to end cancer

Resources

Programs